Announced positive Phase 1 data for SION-719 and SION-451 demonstrating both first-in-class NBD1 stabilizers were generally ...

The Phase 1b program is designed to evaluate the clinical activity of NXP900 as a single agent in patients with advanced ...

We are pleased with the progress we’ve made this past quarter, underscored by the encouraging tolerability and PK data from the Phase 1 trials of ...

Immunome's varegacestat shows promising efficacy in desmoid tumors, with phase 3 topline data expected by 2025-end. Read why ...

If approved, Novartis' ianalumab would become the first targeted treatment for patients with Sjögren’s disease.

An ankle sprain on Mars? An earache on the Moon? NASA and Google are building a proof-of-concept AI medical assistant ...

SAN DIEGO - Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) reported a significant revenue shortfall in the second quarter as the company continues to advance its pipeline of mRNA therapeutics and ...

Scientists have found that microscopic gold clusters can act like the world’s most accurate quantum systems, while being far ...

As AI transitions from experimentation to widespread implementation, organizations are looking for secure, scalable, and developer-friendly platforms to maintai ...

Brands could justify the higher weights because super shoes improved running economy in most runners by far more than 1 ...

The creation of a woolly-mouse embryo marks a significant leap in the field of de-extinction, bringing us one step closer to ...

By successfully establishing a foothold in Singapore, Shawarma Shack aims to demonstrate the viability and appeal of its fast ...